课题基金 / 基金详情

MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL

MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL
酪氨酸激酶信号作用的机制研究
批准号:
12670427
负责人:
NAKANO Shuji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

NAKANO Shuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Activation of Src and Ras has been demonstrated be closely associated with the pathogenesis and metastatic potential of many human tumors. However, the role of these oneogenes in the drug sensitivity and invasion process remain to be clarified. We examined the role of Src and Ras on these processes, using HAG-1 human epithelial cell lines transfected with v-src and activated H-ras. First we examined the potential role of Ras and Rac, a small GTPase binding protein which acts downstream of Ras, by introducing adenoviral vector containing dominant negative Ras and Rac (DN/Ras and DN/Rac) into these cells. Both DN/Ras and DN/Rac reduced the invasive potential of src-transfected cells. Moreover, DN/Rac suppressed completely the tumorigenic potentials of src-transfected cells in nude mice. These results suggest that Src, Ras, Rac, all appeared to participate in the invasion processes, and that Rac may act downstream of these signaling pathways of invasion and tumorigenicity. Next we have ex … More amined the effect of activated Src on the sensitivity to taxotere, an anticancer drug targeting microtubules. As compared with parental HAG-1 cell line, v-src-transfected HAG/src3-l cells became 7.0-fold sensitive to taxotere. The taxotere sensitivity in HAG/src3-1 cells was reversed by herbimycin A (HA), indicating that Src tyrosine kinase augments sensitivity to taxotere. Treatment of HAG/src3-1 cells with taxotere resulted in phosphorylation of Bel-2 and subsequent induction of apoptotic cell death, whereas neither Bcl-2 phosphorylation nor apoptosis occurred in parental or c-H-ras-transfected HAG-1 cells. The Bcl-2 protein is overexpressed in v-src-transfected cell line. Treatment of HAG/src3-1 cells with HA reduced the expression and phosphorylation of Bcl-2, and abrogated taxotere-induced apoptosis, suggesting a potential role for Src tyrosine kinase in the taxotere-induced apoptotic events. H-7, and wortmannin, PI-3 kinaseinhibitor, neither altered taxoteresensitivity nor inhibited taxotere-induced apoptosis in these cells. These data indicate that the ability of activated Src to increase taxotere sensitivity would be mediated by apoptotic events occurring through Src to downstream signal transduction pathways toward Bcl-2 phosphorylation, but not by activated Ras, PI-3 kinase or protein kinase C. Less
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Koizumi W: "Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer"Oncology. 58. 191-197 (2000)
Koizumi W:“S-1(一种新型口服 5-氟尿嘧啶衍生物)在晚期胃癌中的 II 期研究”肿瘤学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato K., Nomoto M., Izumi H., Nakano S., Niho Y. Kohno K.: "Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin struciure as a possible mechanism for the upregulation in cisplatin-resisiam cell"Biochim. Biophys. Act
Kato K.、Nomoto M.、Izumi H.、Nakano S.、Niho Y. Kohno K.:“人类 STAT3 基因启动子的结构和功能分析:染色质结构的改变是顺铂-resisiam 上调的可能机制
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koizumi W., Kurihara M., Nakano S., Hasegawa K.: "Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouraeil, in Advanced Gastric Cancer"Oncology. 58 (3). 191-197 (2000)
Koizumi W.、Kurihara M.、Nakano S.、Hasekawa K.:“5-Fluorouraeil 新型口服衍生物 S-1 在晚期胃癌中的 II 期研究”肿瘤学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sawabe T., Horiuchi T., Nakamura M., Tsukamoto H., Nakahara T., Harashima SI., Tsuchiya T., Nakano S.: "Defect of lck in aient with common variable immunodeficiency"Int. J. Mol. Med.. 7 (6). 609-614 (2001)
Sawabe T.、Horiuchi T.、Nakamura M.、Tsukamoto H.、Nakahara T.、Harashima SI.、Tsuchiya T.、Nakano S.:“常见变异型免疫缺陷患者的 lck 缺陷”Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Mechanistic study for the anti-cancer effects of phytochemicals against breast and colon cancers
    • 批准号:
      24501020
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      NAKANO Shuji
    • 依托单位:
    Basic and Epidemiological study for the carcinogenic role of obesity and nutritional factors in breast and colon cancers
    • 批准号:
      20500734
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      NAKANO Shuji
    • 依托单位:
    Identification of signal transduction that induces anticancer drug resistance for clinical application
    MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL TRANSDUCTION IN THE INVASION POTENTIAL AND APOPTOSIS OF TUMOR CELLS
    • 批准号:
      14570416
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2002
    • 负责人:
      NAKANO Shuji
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: